ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0619

Racial and Ethnic Disparities in Pregnancy Outcomes Among Women with Rheumatic Diseases: A Systematic Literature Review and Quantitative Analysis

Maya Swaminathan1, Gloria Shen2, Irvin Huang2, Diana Louden2, Waqas Tahir3 and Namrata Singh4, 1MultiCare Good Samaritan Hospital, Newcastle, WA, 2University of Washington, Seattle, WA, 3Rochester General Hospital, Rochester, MN, 4University of Washington, Bellevue, WA

Meeting: ACR Convergence 2021

Keywords: Disparities, pregnancy, race/ethnicity, Rheumatic diseases, Women's health

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 7, 2021

Title: Healthcare Disparities in Rheumatology Poster (0594–0622)

Session Type: Poster Session B

Session Time: 8:30AM-10:30AM

Background/Purpose: Women are disproportionately affected by rheumatic diseases (RD), with many of them carrying the diagnosis in their childbearing years. Pregnant women with RD have a high prevalence of adverse pregnancy outcomes (APO) owing to a multitude of factors. Racial/ethnic disparities in APO are well-recognized in the general population, however the understanding for this among women with RD is limited. While there are studies which have explored the impact of race/ethnicity on APO among patients with RD, limitations of RD type and race ascertainment prevent single studies from synthesizing a complete analysis. We conducted a systematic literature review to evaluate the impact of race/ethnicity on APO in women with RD.

Methods: Systematic literature searches in PubMed, Embase, and Cumulative Index for Nursing and Allied Health Literature (CINAHL) Complete were conducted to identify potentially eligible studies. Inclusion criteria consisted of all study designs except for case reports and narrative reviews, presence of RD and APO, and data pertaining to race/ethnicity. Conference abstracts published before 2015 and non-English articles were excluded.

Results: A total of 1540 references remained after duplicates were removed of which full text review was done for 27 articles (Figure 1). These were independently reviewed by three co-authors (GS, IJH, and MS) and discrepancies were resolved by a fourth co-author (NS). Study quality was assessed using Newcastle-Ottawa Scale. Ten studies met our eligibility criteria to be included in the literature review (Table 1).

Of the 10 studies, 7 were from North America, 1 from Europe, 1 from Asia, and 1 multicontinental. Most of them were cohort studies, except one that was a cross-sectional study. One study examined racial/ethnic disparities among patients with juvenile idiopathic arthritis (JIA). The remaining 9 studies looked at patients with systemic lupus erythematosus (SLE) of which 2 included patients with antiphospholipid antibody syndrome (APS), and 2 included patients with rheumatoid arthritis (RA).

Because of the significant differences between the studies, pooled analysis could only be carried out using two studies (Figure 2). Among patients with SLE, Black patients had higher odds of APO compared to White patients, with a pooled odds ratio (OR) of 2.40 [95% CI 2.19 – 2.63]. Similarly, Hispanic patients had higher odds of APO compared to White patients with a pooled OR of 1.94 [95% CI 1.75 – 2.14].

Conclusion: This systematic literature review highlights that racial/ethnic minority populations with RD are more prone to APO compared to their White counterparts. Eight out of the nine studies involving White patients are consistent with these findings. Pooled analysis was limited due to multiple factors including heterogeneity in the study population, variation in the outcomes of interest, and different definitions for APO. Standardized criteria for APO are necessary to allow direct comparisons between studies. SLE has been the focus in most of these studies and there is a paucity of data looking at other RDs. Further research is needed to explore the causes for the racial/ethnic disparities and how these can be addressed.

Figure 1: PRISMA Flow Diagram showing study selection process

Table 1: Characteristics of studies included in the systematic literature review

Figure 2: Forest plot comparing adverse pregnancy outcomes in SLE between A) Black and White patients, and B) Hispanic and White patients


Disclosures: M. Swaminathan, None; G. Shen, None; I. Huang, None; D. Louden, None; W. Tahir, None; N. Singh, None.

To cite this abstract in AMA style:

Swaminathan M, Shen G, Huang I, Louden D, Tahir W, Singh N. Racial and Ethnic Disparities in Pregnancy Outcomes Among Women with Rheumatic Diseases: A Systematic Literature Review and Quantitative Analysis [abstract]. Arthritis Rheumatol. 2021; 73 (suppl 9). https://acrabstracts.org/abstract/racial-and-ethnic-disparities-in-pregnancy-outcomes-among-women-with-rheumatic-diseases-a-systematic-literature-review-and-quantitative-analysis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2021

ACR Meeting Abstracts - https://acrabstracts.org/abstract/racial-and-ethnic-disparities-in-pregnancy-outcomes-among-women-with-rheumatic-diseases-a-systematic-literature-review-and-quantitative-analysis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology